191.53
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
13.46%
505.13
|
445.22 | 361.63 | 315.27 | 264.71 |
| Operating Income/Loss |
13.46%
-505.13
|
-445.22 | -361.63 | -315.27 | -264.71 |
| Nonoperating Income/Loss |
1,520%
-139.24
|
-8.594 | -3.266 | 10.06 | 16.93 |
| Income/Loss From Continuing Operations Before Tax |
41.99%
-644.37
|
-453.82 | -364.89 | -305.21 | -247.79 |
|
|
41.99%
-644.37
|
-453.82 | -364.89 | -305.21 | -247.79 |
| Basic Average Shares |
6.46%
210.89
|
198.10 | 1.4716 | 189.23 | 188.58 |
| Diluted Average Shares |
6.46%
210.89
|
198.10 | 1.4716 | 189.23 | 188.58 |
| Basic Earnings Per Share |
33.62%
-3.06
|
-2.29 | -1.89 | -1.61 | -1.31 |
| Diluted Earnings Per Share |
33.62%
-3.06
|
-2.29 | -1.89 | -1.61 | -1.31 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):